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Abstract
Background: Chronic endometritis (CE) is a continuous inflammation of uterine endometrium, and it is usually
symptomless. As CE has been thought not to affect the reproductive status and general health of affected
women, its significance has not been explored. However, recent studies have shown that CE is related with
repeated implantation failures after in vitro fertilization-embryo transfer, unexplained infertility, and recurrent
miscarriages. As decidua differentiates to support the implantation process and maintains the pregnancy, we
hypothesized that CE may influence the process of decidualization.
Methods: Seventeen patients were employed in the experiment involving culture of endometrial stromal cells (ESCs).
After obtaining endometrial samples, ESCs were harvested and cultured for 13 days. The concentrations in culture
media and the protein expressions in ESCs of prolactin (PRL) and insulin-like growth factor binding protein-1 (IGFBP-1),
two well known decidualization markers used in a large number of in vitro models, were analyzed by ELISA and
Western blotting, respectively, and the cell numbers were also counted. The mRNA levels of PRL and IGFBP-1 were
tested by quantitative real time polymerase chain reaction (RT-PCR). Since sex hormone induce proliferation and
differentiation to decidua via binding to the sex hormone receptors (ERα, ERβ, PRA, and PRB), their expression was
assessed in another 17 patients’ paraffin-embedded endometrial tissue specimens by immunohistochemistry and
semi-quantified by H-score.
Results: Increased cell numbers and reduced secretion of PRL and IGFBP-1 were detected by ELISA in the
ESCs of CE patients after culture for 13 days compared with non-CE patients. The decreased protein
expression of IGFBP-1 in ESCs of CE patients was detected by Western blotting. The decreased expression of
PRL mRNA and IGFBP-1 mRNA were detected by RT-PCR. Increased expressions of ERα, ERβ, PRA, and PRB
were observed in the stromal cells of CE patients in comparison to non-CE patients, whereas increased
expressions of ERα and ERβ were detected in the glandular cells of CE.
Conclusion: Our data suggests that CE modifies decidualization of human ESC through untuning the function
of sex steroid hormone receptor.
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Background
Chronic endometritis (CE) is a disease of continuous and
subtle inflammation of the uterine endometrium. It is also
called subclinical endometritis because it is usually symp-
tomless or presents only with subtle symptoms such as
abnormal uterine bleeding, pelvic pain, dyspareunia, and
leucorrhea [1]. CE was thought to be caused by a variety
of infectious agents such as bacteria, viruses, and para-
sites, but the precise cause of CE remains unclear [2]. It is
diagnosed by the presence of plasma cells, which are never
present under normal conditions, within the endometrial
stromal layer to show the existence of a continuous
immune response to some substance(s) or agent(s) in the
endometrium [1, 3].
Since CE has been thought not to affect the reproduct-
ive status and general health of affected women [1], its sig-
nificance has not been explored. However, recent research
has shown a higher prevalence of CE in infertile patients
(range 2.8 to 46%) [4–8] and relationships with recurrent
abortion and repeated implantation failure [4, 9, 10].
Furthermore, a new clinical study reported that CE
decreases the success rate of in vitro fertilization (IVF)
[11]. These results suggest that CE affects uterine recep-
tivity for the embryo and impairs successful pregnancy.
Endometrial stromal cells (ESCs) undergo the process of
decidualization [12]. Decidua is transformed under the in-
fluence of estrogen and progestogen and differentiates to
maintain the pregnancy. It exchanges nutrition, gas, and
waste between the fetus and mother in cooperation with
the placenta. Decidua also produces hormones, growth
factors, and cytokines such as prolactin (PRL) [12–14],
corticotrophin releasing factor (CRF) [15, 16], insulin-like
growth factor binding protein-1 (IGFBP-1) [12, 17], and
interleukin-15 [18, 19]. It may regulate the invasion of the
trophoblast and the attack from the maternal immune
system [20, 21]. Given the adverse effects of CE on the
implantation process in clinical studies and the role of
decidua, CE may modify the process of decidualization.
Another gynecological disease that may cause infertil-
ity and implantation failure is endometriosis, affecting
10–15% women of reproductive age [22, 23]. It is char-
acterized by the appearance of hormone-sensitive
endometrial-like tissue outside the uterine cavity [24].
Eutopic ESCs from endometriosis patients exhibit a
reduced response to decidualization in primary culture,
which suggests that abnormal differentiation of the
eutopic endometrium is related to infertility [25, 26]. Re-
cently, an article reported that 52.94% of endometriosis
patients are diagnosed with CE compared to only
27.02% of non-endometriosis patients [27]. This fact also
suggests that CE may be involved in the modification of
decidualization in eutopic endometrium.
To explore the effects of CE on decidualization, the ex-
pressions of PRL and IGFBP-1, markers of decidualization,
were analyzed in primary culture of human ESCs. In
addition, the expressions of sex steroid hormone recep-
tors, estrogen receptors α and β (ERα, ERβ) and progester-
one receptors A and B (PRA, PRB) were analyzed by
immunohistochemistry.
Methods
Collection of samples for culture experiment
The patients underwent urine LH testing provided from
our hospital daily from 3 or 4 days before the estimated
ovulation date. On the day or the day after the urine test
became positive, the patients visited our hospital and the
status of follicle growth was confirmed. When follicle
growth was sufficient as preovulatory follicle, the patient
was planned to undergo hysteroscopy and curettage at 7 or
8 days after predicted ovulation. When endometrial polyps
were found at hysteroscopy, the patients were excluded. On
the day of hysteroscopy and curettage, blood samples were
obtained to measure serum levels of estradiol (E2) and
progesterone (P4). Endometrial tissue obtained by first cur-
ettage from each patient was sent to the pathology depart-
ment. Mild curettage was performed a few more times to
obtain endometrial tissue for the culture experiment. The
tissues of first curettage were fixed in 10% formaldehyde,
embedded in paraffin, and sectioned at 4 μm. According to
the criteria of Noyes et al., the section was stained with
hematoxylin and eosin for histological examination and
judging of the date of the endometrial phase [28]. More-
over, the sections were immunostained with anti-CD138
antibody (product no.B-A38, Nichirei Corp.) as we previ-
ously reported or used for immunostaining for sex steroid
hormone receptors. The criteria of CE diagnosis was the
observation under microscopy with a high powered field of
two or more CD138-positive cells in the stromal layer [29].
The diagnosis of CE and endometrial dating was performed
by investigators (FK, MI) and the investigators performing
the culture experiments (DW, LZ, YN) were blinded to the
CE status of the sample until all procedures of cell culture,
cell counting and ELISA were completed and all results
were obtained.
The patients’ age, parity, gravidity, body mass index
(BMI), endometrial thickness, and causes of fertility in-
cluding the diagnosis of endometriosis were obtained
from the patients’ records. Endometriosis was diagnosed
when the existence of endometrioma was confirmed by
MRI or stage III or IV endometriosis was confirmed by
laparoscopy within 2 years before participation in this
study. The information with endometriosis was used for
the subanalysis of following experiment as endometriosis
may affect the result.
Isolation and culture of ESCs
The endometrial tissues obtained from 17 patients, nine
CE patients including five endometriosis patients and 8
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non-CE patients including 4 endometriosis patients,
were used to perform primary cell culture as we previ-
ously reported [30]. Briefly, after mince, these endomet-
rial tissue pieces were incubated for 1 h at 37 °C in a
humidified atmosphere of 5% CO2 in air with 0.2%
collagenase (Sigma) and 0.005% deoxy ribonuclease I
(Worthington Biochemical Co.), with gentle pipetting
every 15 min. After digestion, 20 mL of DMEM/F12
(1:1) (1×) (Life technologies) replenished with 10% char-
coal striped FBS (HyClone GE Healthcare Life Sciences)
were added, and the cell suspension was placed in the
upright position for 3 min. Then, the supernatant
including the rich fraction of stromal cells was filtered
through the 40-μm cell strainer (Falcon Life Sciences)
and then centrifuged for 10 min at room temperature.
After the pellet was resuspended, a total of 400,000
viable cells per well were transferred into six well
multidish (Thermo Fisher Scientific). The ESCs were
cultured at 37 °C in a humidified atmosphere of 5% CO2
in air with 2 mL of DMEM replenished with 10% FBS,
100 IU/mL penicillin, and 100 μg/mL streptomycin.
After 1 h, the culture media were exchanged to culture
media including estradiol 3 × 10−10 mol/L (81.7 pg/mL)
(Sigma) and progesterone 5 × 10−8 mol/L (15.7 ng/mL)
(Nacalai Tesque, Inc.). The culture media were changed
every other day, and the ESCs were cultured for 13 days.
The culture media were changed 24 h before the collec-
tion of culture media and cell harvest. The culture
media were collected, centrifuged at room temperature
followed by the collection of supernatant, and stored at
−80 °C for later analysis. The numbers of ESCs in a dish
were counted by the inverted microscope with cell coun-
ter after exposure to 1 mL of 0.05% trypsin and 0.02%
EDTA in PBS for a few minutes, followed by deactiva-
tion by adding 1 mL of DMEM/F12 with 10% FBS.
ELISA to detect PRL and IGFBP-1 in culture media
The levels of PRL and IGFBP-1 in culture media were
measured by ELISA kits (Prolactin Picokine ELISA
Kit, Product no. EK0593, Boster Biological Technol-
ogy. Ltd.; Human Free IGFBP-1 Quantikine ELISA
Kit, Product no. DGB100, RSD R&D Systems Inc.)
following the manufacturers’ instructions. The con-
centrations of PRL secreted by a cell was calculated
by the formula: [PRL] x [volume ratio]/cell number.
Where [PRL] represents the concentration of PRL in
culture media assessed by ELISA (pg/L), and [volume
ratio] indicates the actual volume of collected
medium in one well (mL) divided by 2 mL (the initial
volume of culture media). Cell number means the
total cell number in the well. The concentration of
IGFBP-1 secreted by a cell was obtained using an
identical calculation.
Protein extraction from cultured cells and western
blotting
After discarding the supernatant, the cells on wells were
washed twice with PBS. RIPA buffer (200 μL: 20 μL 1%
SDS, 20 μL RIPA Buffer with protease inhibitor cocktail
and 160 μL DW, Nacalai Tesque, Inc.) was added to the
well. The cells on wells were cooled for 5 min on ice,
collected with the cell scraper to be homogenized, and
centrifuged at 10000 × g at 4 °C for 10 min. The super-
natant was collected and kept at −80 °C until used for
Western blotting.
The protein (10 μg) was boiled in Laemmli solution
under reducing condition at 95 °C for 7 min. The solu-
tions from CE and non-CE patients and Protein Ladder
One Triple-color (Nacalai Tesque) were electrophoresed
on a 15% SDS–polyacrylamide gel (Wako Pure Chemical
Industries) and then transferred to a polyvinylidene
difluoride membrane (Millipore). Membranes were incu-
bated with 20% blocking reagent-N102 (NOF Co.) in
25 mM TBS containing 0.1% Tween-20 (TBST; pH 7.4)
at room temperature for 1 h to block non-specific
protein binding sites, followed by incubation with the
IGFBP-1 antibody (1: 1000; Santa Cruz Biotechnology,
Inc.) or GAPDH (1:5000; Enzo Life Science, Inc.) diluted
by TBST at 4 °C overnight. After washing with TBST for
20 min thrice, the membranes were reacted with a
peroxidase-labeled anti-mouse IgG (1:50,000; GE
Healthcare) for 1 h at room temperature. Peroxidase
labeling was detected by chemiluminescence using the
Chemi-Lumi one super (Nacalai Tesque).
RNA extraction from culture cells and real-time polymerase
chain reaction
Total RNA was extracted from ESCs after culture for
13 days with RNeasy Micro kit (QIAGEN.) following the
manufacturer’s instructions. Each sample (100 ng) was
reverse transcribed using the Prime Script RT Master
Mix (Takara Biotechnology. Co., Ltd.). Real-time PCR
was performed using the LightCycler 480 SYBR Green I
Master (Roche Diagnostics International Ltd.) with
specific primer pairs for PRL, IGFBP-1 and GAPDH as
follows: PRL, F:5’- GCCCCCTTGCCCATCTGTCG-3’
and R:5’- AGAAGCCGTTTGGTTTGCTCC -3’; IGFBP-
1, F:5’- TGCTGCAGAGGCAGGGAGCCC -3’ and R:5’-
AGGGATCCTCTTCCCATTCCA -3’ (Takara); GAPDH,
F:5’- AAATCCCATCACCATCTTCCA -3’ and R:5’-
AATGAGCCCCAGCCTTCTC -3’ (Sigma).
The mixture of reaction reagents was incubated at 95 °
C for 5 min and cycled according to the following pa-
rameters: 95 °C for 10 s, 55 °C for 15 s, and 72 °C for
10 s for a total of 45 cycles, followed by cooling for 10 s
at 50 °C by LightCycler 480TL system II (Roche
Diagnostics International Ltd.). Melting curve analysis
was performed.
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Immunohistochemistry for endometrial tissue specimens
The stocked paraffin-embedded endometrial tissue
specimens obtained from 156 infertile patients from 7 to
8 days after ovulation to diagnose the endometrial dating
and CE were the candidates for the study of immunohis-
tochemistry. The diagnosis of CE was done by the same
method of the culture experiment of the present study.
If endometrial disease such as endometrial hyperplasia
or polyp were diagnosed, the samples were excluded
from the study. Seventeen samples (eight samples of CE
and nine samples of non-CE) were randomly chosen for
the analysis by an investigator (FK) when the endomet-
rial dating of the phase in the endometrium pathologic-
ally determined according to the criteria of Noyes et al.
was in the phase between 7 and 9 days in the secretory
phase [28]. At that time the investigator was blinded to
the patients’ character except the diagnosis of CE and
endometrial dating. The patients’ age, parity, gravidity,
BMI, endometrial thickness, and causes of fertility were
obtained from the patients’ records after the following
experiments of immunohistochemistry were completely
diagnosed by other investigators.
The paraffin-embedded blocks were cut into 4-μm-
thick sections. After deparaffinization and rehydration,
the slides were immersed into 3% Tritonx-100 in PBS
for 15 min and heated in a pre-heated sodium citrate
buffer (pH 6.0) at 98 °C for 20 min. After infusion in 3%
hydrogen peroxide for 10 min, the sections were covered
with 5% BSA in PBS for 25 min followed by incubation
with the primary antibodies as follows: ERα (1:50; Prod-
uct no. sc-8005, Santa Cruz Biotechnology) at 4 °C for
3 days, and ERβ (1:200; Product no. ab288, Abcam),
PRA (use directly;Product no. PA0312, Leica Biosystems
Newcastle Ltd.) and PRB (1: 200; Product no.3157S, Cell
Signaling Technology, Inc.) at 4 °C overnight, incubated
with horseradish peroxidase-conjugated secondary anti-
body for 30 min at room temperature, and developed
with DAB. The slides were immersed into hematoxylin
counterstain for 1 min, underwent gradient alcohol
dehydration followed by the xylene process, and
mounted with neutral resin for later observation under
an inverted microscope (BH-2, Olympus Co.).
Scoring of immunoreactivity for endometrial tissue
specimens
In order to semi-quantitatively analyze the immunoreac-
tivity of nuclear steroid receptors, the H-score was used
[31]. Briefly, the cells of more than 500 ESCs or glandu-
lar cells were each scored using three degrees: strongly
stained nuclei (two points), moderately stained nuclei
(one point), and negative stained nuclei (zero points).
The H-score was subsequently calculated by summing
the numbers of each point multiplied by the percentage
of the point.
Statistical analysis
All data are expressed as means ± standard error of the
mean (S.E.M). An unpaired t-test unpaired or the Mann
Whitney test was performed based on whether that dis-
tribution was Gaussian using GraphPad Prism ver.7.00.
A value of P < 0.05 was considered significant.
Results
CE affects the decidualization of ESCs
This study included samples of nine CE patients and
eight non-CE patients (Table 1). Age, parity, gravidity,
BMI, the levels of E2 and P4, endometrial thickness,
and the rate of out-of-phase endometrium were not
different between the CE and non-CE groups.
Table 1 Clinical characteristics of the patients participating in the study for ELISA, Western blotting and quantitative RT-PCR
non-CE (N = 8) CE (N = 9) P value
Age (y) 37.9 ± 0.67 35.4 ± 1.80 0.25
Parity 1.00 ± 0.33 0.33 ± 0.24 0.11
Gravidity 0.38 ± 0.19 0.11 ± 0.11 0.23
BMI (kg/m2) 22.9 ± 1.32 22.9 ± 1.59 1.00
E2 (pg/mL) 117 ± 25.0 142 ± 29.14 0.54
P4 (ng/mL) 9.76 ± 1.86 13.21 ± 1.84 0.21
Endometrial thickness (mm) 8.89 ± 1.03 8.90 ± 0.65 0.99
Out of phase (%) 0.38 (3/8) (0.67) 6/9 0.35
Cause of infertility Male : 3 Male : 2
Tubal factor : 2 Tubal factor : 1
Endometriosis : 4 Endometriosis : 5
Unknown: 1 Unknown: 3
Age, parity, gravidity, body mass index (BMI), the levels of E2 and P4, endometrial thickness, and the rate of out-of-phase endometrium were not different
between the CE and non-CE groups
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The concentration of PRL secreted by a cell was
obviously decreased in the CE group compared with
the non-CE group (P < 0.01) (Fig. 1a). In addition, the
concentration of another marker of decidualization,
IGFBP-1, was also significantly reduced in the CE
group compared with the non-CE group (P < 0.01)
(Fig. 1b). The cell number of decidualized ESCs after
culture for 13 days was obviously increased in the CE
group compared with the non-CE group (P < 0.05)
(Fig. 1c).
Since decidualization has been reported to be dis-
turbed in the eutopic endometrium of endometriosis,
only the samples with endometriosis were evaluated
in the CE group (five patients) and non-CE group
(four patients). In the patients suffering from both endo-
metriosis and CE, the concentration of PRL tended to be
decreased compared with the patients with endometriosis
without CE (P = 0.09) (Fig. 1d). The concentration of
IGFBP-1 produced by cells in patients with both CE and
endometriosis was decreased compared with the endomet-
riosis patients without CE (P < 0.05) (Fig. 1e). The cell num-
bers of patients with endometriosis was not increased in
the CE group compared with the non-CE group (P = 0.11)
(Fig. 1f).
In addition, a different expression of IGFBP-1 in ESCs
between CE and non-CE group was detected by Western
blotting (P < 0.01) (Fig. 2a and b). A difference in the
production of IGFBP-1 was also confirmed in patients
with both CE and endometriosis compared with the
endometriosis patients without CE by western blotting
(P < 0.05) (Fig. 2a and c).
The mRNA levels of PRL and IGFBP-1 were signifi-
cantly lower in the CE group than in the non-CE group
(P < 0.05) (Fig. 3a and b). When only the samples with
endometriosis were evaluated in the CE group (five pa-
tients) and the non-CE group (four patients), the mRNA
levels of PRL and IGFBP-1 tended to be decreased in
the CE group (P = 0.06 in both) (Fig. 3c and d).
Immunohistochemistry of ERα, ERβ, PRA, and PRB
The tissues for immunohistochemistry assay were ob-
tained from 17 patients, including nine non-CE patients
and 8 CE patients. Age, parity, gravidity, BMI, the levels
of E2and P4 and endometrial thickness were not different
between the CE and non-CE groups (Table 2). ERα, ERβ,
PRA, and PRB immunoreactivities were examined on par-
affin sections in the non-CE group (Fig. 4a, c, e, and g)
and the CE group (Fig. 4b, d, f, and h). The H-Scores of
these receptors in stromal cells and glandular cells in the
non-CE group and the CE group are shown in Fig. 3 i, j, k,
and l. Higher expressions of ERα and ERβ were present in
stromal cells in the CE group (P < 0.005 and P < 0.05) and
Fig. 1 Secretion of PRL and IGFBP-1 from decidualized ESCs in vitro and cell numbers. Samples with endometriosis in the CE group and non-CE
group were indicated by “Endo”. a The concentration of PRL in the media of cultured ESCs evaluated by ELISA. PRL concentration is lower in CE
samples than in non-CE samples (P < 0.01). b The concentration of IGFBP-1 analyzed by ELISA. The data are shown using a log scale.
Lower expression of IGFBP-1 is observed in CE samples than in non-CE samples (P < 0.01). c The number of stromal cells after culture for
13 days. It is obviously higher in the CE group than in the non-CE group (P < 0.05). d The concentration of PRL in the patients with
endometriosis divided into the CE and non-CE groups. The level of PRL tends to be lower in the CE group than in the non-CE group
(P = 0.09). e The concentration of IGFBP-1 in the patients with endometriosis separated into the CE and non-CE groups. The concentration
of IGFBP-1 is lower in the CE group than in the non-CE group (P < 0.05). f The cell number of the patients with endometriosis divided
into the CE and non-CE groups. The cell numbers are not different between the CE group and the non-CE group (P = 0.11)
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there was a significant difference in both stromal cells and
glandular cells (P < 0.05 and P < 0.01), although the differ-
ence of absolute value of ERα and ERβ expressions in
glandular cells were inconspicuous in the CE group in
comparison with the non-CE group (Fig. 4a, b, c, d, i, and
j). Higher expressions of PRA and PRB in stromal cells
were seen in the CE group (P < 0.001 and P < 0.0001),
whereas PRA and PRB expressions were similar in the epi-
thelia between the CE group and the non-CE group
(Fig. 4e, f, g, h, k, and l).
Discussion
Although previous studies suggested that CE affected
the uterine receptivity of the endometrium to embryo,
little information is available about the mechanism. This
is the first study to assess the effect of CE on deciduali-
zation of ESCs. Decidualization plays crucial roles in
trophoblast invasion, the endometrial immune response
of the feto-maternal interface [20, 21, 32], and the estab-
lishment of the placenta. These may suggest that dis-
turbance of the decidualization process emerges the
correlation with infertility and miscarriage [33, 34].
In the present study, the ESCs of CE had significantly
lower expressions and secretion of PRL and IGFBP-1 in
vitro after the induction of decidualization compared
with the ESCs of non-CE. Moreover, the number of
ESCs after culture for 13 days with E2 and P4 treatment
to induce decidualization was significantly higher in the
CE group than in the non-CE group. The modification
of differentiation was connected with the promotion of
proliferation. CE modifies decidualization in vitro and
weakens the action of P4 on ESCs, resulting in less po-
tential to differentiate and greater potential to
proliferate. In 3 CE patients with no or extremely low
levels of PRL and IGFBP-1 secretion, the number of
ESCs was extremely high, approximately 3-fold higher
than that in non-CE patients (Fig. 1), and the ESCs
proliferated and differentiated like as exposed to only E2.
In the culture experiment, CE was diagnosed in nine
of 17 patients, endometriosis was diagnosed in nine of
17 patients, and five of 17 patients was suffered from CE
and endometriosis. The main reason why the samples
we obtained included higher percentage of CE and endo-
metriosis patients is thought to be that we chose
patients of endometriosis and refractory infertility when
we enrolled as these were the risk of CE.
Previous studies reported that the capacity of eutopic
endometrial stromal cells for decidualization was re-
duced, whereas the proliferation potential was increased
in endometriosis patients [25]. Since the present result
might be due to the effect of endometriosis, only sam-
ples with endometriosis were chosen and analyzed. Our
data shown that the significantly reduced protein level
and mRNA expression of PRL and IGFBP-1 and the
increase of cell number were oppositely observed in the
CE patients compared with non-CE patients, no matter
whether the patients have endometriosis or not. This
result suggest that CE affected the differentiation of cul-
tured ESCs and modified decidualization independently
of endometriosis.
Although the number of samples in this experiment
was relatively low, a significant difference was apparent
between CE and non-CE in terms of the secretion of
decidual proteins and cell numbers. This may cause by
the specifically developed methods for this experiment.
The first thing is that the endometrial samples were
Fig. 2 Western blotting of IGFBP-1 in ESCs. Samples with endometriosis in the CE group and non-CE group were indicated by “Endo”. a Western
blotting of IGFBP-1 and GAPDH. Endo under the blots indicates endometriosis patient. b The ratio of production of IGFBP-1 per GAPDH in all
patients. The production of IGFBP-1 is significantly reduced in the CE group compared to the non-CE group (P < 0.01). c The ratio of production
of IGFBP-1 per GAPDH in endometriosis patients. The production of IGFBP-1 in patients with both CE and endometriosis is also decreased
compared with endometriosis patients without CE (P < 0.05)
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obtained in the mid-secretory phase. CE is thought to be
caused by the continuous and subtle infection of some
agent inside the uterus. When the ESCs obtained in the
proliferative phase are used in primary culture, the in-
duction of decidualization starts with the regulation of
inflammation by antibiotics in the culture media. The
removal of endometrial cells from the uterus with CE
leads to the cessation of exposure to inflammation and
immune cells in the uterus and the beginning of treat-
ment for the infection with antibiotics in vitro. However,
using the sample obtained in the secretory phase, the
ESCs are already exposed to inflammation and immune
cells during the initial process of decidualization in vivo.
As reported in the present study, the expression of sex
steroid receptors is already modified at the mid-
secretory phase in in vivo endometrium of CE patients
even with the collection of the endometrial date for the
phase.
The second point is that lower concentrations of E2
and P4 were used in the present study compared with
previous studies, whereas the concentrations are identi-
cal to in vivo conditions. In many previous reports
higher levels of E2 and P4 than in the in vivo condition,
cyclic adenosine monophosphate (cAMP) or medroxy-
progesterone acetate (MPA) have often been used to in
vitro experiments to make the experiments stable [35–
37]. We previously reported that the difference in the re-
sponse to secrete decidual proteins becomes larger
among samples with a decreased P4 concentration in the
medium [30]. These suggested that milder impairment
of the endometrium by CE may be masked with expos-
ure to higher levels of E2, P4, cAMP, or MPA.
Mishra et al. have already shown the higher expres-
sions of ER and PR in ESCs in the secretory phase of CE
patients and the result is identical to our result although
the expression of hormone receptor subtypes was not
investigated. The effects of estrogen develop in the endo-
metrium through two main classical estrogen receptor
(ER) isoforms, ERα and ERβ, whereas progesterone acts
by binding its two predominantly progesterone receptor
Table 2 Clinical characteristics of the patients participating in
the study for IHC for sex steroid hormone receptors
non-CE (N = 9) CE (N = 8) P value
Age (y) 37.0 ± 1.19 37.3 ± 2.61 0.24
Parity 0.44 ± 0.24 0.75 ± 0.25 0.34
Gravidity 0.11 ± 0.11 0.38 ± 0.18 0.24
BMI (kg/m2) 21.2 ± 0.86 20.7 ± 0.86 0.73
E2 (pg/mL) 109 ± 16.9 151 ± 28.1 0.093
P4 (ng/mL) 14.6 ± 1.66 18.1 ± 3.21 0.32
Endometrial thickness (mm) 9.40 ± 1.14 8.67 ± 1.54 0.70
Age, parity, gravidity, body mass index (BMI), the levels of E2 and P4 and
endometrial thickness were not different between the CE and non-CE groups
Fig. 3 The mRNA levels of PRL and IGFBP-1 in decidualized ESCs in vitro. Samples with endometriosis in the CE group and non-CE group were
indicated by “Endo”. a The mRNA level of PRL in the decidualized ESCs. The level is lower in the CE group. b The mRNA level of IGFBP-1 in the
decidualized ESCs. The level is lower in the CE group. Patients with endometriosis are divided into the CE and non-CE groups. c and d the mRNA
level of PRL and IGFBP-1tends to be lower in the CE group than in the non-CE group (P = 0.06 in both)
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Fig. 4 IHC staining for ERα, ERβ, PRA, and PRB in non-CE and CE patients. a ERα immunoreactivity in the non-CE group. b ERα immunoreactivity
in the CE group. c ERβ staining in the non-CE group. d ERβ immunoreactivity in the CE group. e PRA immunoreactivity in the non-CE group. f
PRA staining in the CE group. g PRB immunoreactivity in the non-CE group. h, PRB immunoreactivity in the CE group. N-Str, C-Str, N-Epi, and
C-Epi mean stromal cells in the non-CE group, stromal cells in the CE group, epithelial cells in the non-CE group, and epithelial cells in the CE
group, respectively. i The H-Score for ERα. The H-Score shows that ERα in stromal cells is higher in the CE group than in the non-CE group
(P < 0.005), and the expression is higher in glandular cells of the CE group than of the non-CE group (P < 0.05). j The H-Score for ERβ. The H-Score
shows that ERβ in stromal cells in the CE group is higher than in the non-CE group (P < 0.05), and the expression is higher in glandular cells of
the CE group than of the non-CE group (P < 0.01). k The H-Score for PRA. The H-Score demonstrates that PRA in stromal cells is higher in the CE
group than in the non-CE group (P < 0.01), but the expression is not significantly different in glandular cells of the non-CE and CE groups. l The
H-Score for PRB. The H-Score shows that PRB in stromal cells in the CE group is much higher than in the non-CE group (P < 0.0001), but its
expression level is similar in glandular cells of the non-CE and CE groups
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(PR) isoforms, PRA and PRB [38, 39]. ERα and PRA are
the predominant isoforms that mediate the critical func-
tions of the uterus for the implantation process and main-
tenance of pregnancy [40, 41]. PRA is the primary
mediator during the secretory phase of decidualization in
humans [42]. The expressions of ERα, PRA, and PRB
decline gradually, both in glandular cells and stromal cells,
during the mid-secretory phase. ERβ appears to show
no change throughout the secretory phase of the
menstrual cycle [42, 43]. Since there are subtypes of
ER and PR and the expressions of sex steroid hor-
mone receptors change with the menstrual cycle, the
expressions of subtypes of ER and PR were examined
only in endometrial samples of the mid-secretory
phase with endometrial dating between day 7 and 9
after ovulation in the present study. The results
showed that the immunoreactivities of ERα, ERβ,
PRA, and PRB in stromal cells were higher in the CE
group, and the expressions of ERα and ERβ were sig-
nificantly higher in the glandular cells of the CE
group. These results suggest that the expressions of
ERs and PRs in stroma and ERs in epithelia are
already different in the mid-secretory phase in CE
patients, even though the endometria differentiate
similarly in morphology. Furthermore, we could not
detect protein expression for PRL and IGFBP-1 in the
same mid secretary samples by IHC and Western
blotting (data not shown). By using RT-PCR only very
low or almost null levels of PRL and IGFBP-1
mRNAs were detected (Additional file 1: Figure S1).
Thus, at the mid secretary phase, decidualization is
still in its early phase and the secretion of deciduali-
zation markers cannot be detected. Taken together,
the abnormal expression of sex hormone receptors
results in difficulty for endometrium to initiate the
decidualization process and modifies the development
of the endometrium for decidualization.
Since CE has been reported to cause recurrent implant-
ation failure after IVF and spontaneous abortion [9, 44],
many researchers have attempted to determine why CE
resulted in poor outcomes of the implantation process. A
recent report showed that altered uterine contractility in
CE patients leads to uterine dysperistalsis, which may be a
significant cause of infertility [45]. In women with CE, an
abnormal pattern of lymphocyte subsets and, consequently,
an aberrant endometrial microenvironment have been
demonstrated [46]. This may be another possibility explain-
ing how CE affects the success of pregnancy. However,
decidualization is a key process to achieve implantation and
pregnancy. This is the first report showing that CE modifies
the process of decidualization. Our results may provide
fundamental evidences for understanding how CE modifies
the decidualization process, consequently, influence the im-
plantation success of IVF and spontaneous abortion.
Conclusions
In summary, the present study showed that in vitro decid-
ualization was modified in CE patients. Furthermore, CE
had an effect on the process of decidualization in depend-
ently of the effect of endometriosis. The sex steroid recep-
tors are aberrantly expressed in the endometrium of CE
patients. These findings suggest that CE affects uterine
receptivity for the embryo and maintenance of the preg-
nancy by the modification of decidualization through
aberrant tuning of sex steroid hormones and their
receptors.
Additional file
Additional file 1: Figure S1. The mRNA levels of PRL (a) and IGFBP-1
(b) in endometrial samples detected by RT-PCR. Total RNA was extracted
from six endometrial samples (three non-CE and three CE) obtained at
mid secretary phase. The expression levels of PRL and IGFBP-1 mRNAs
were very low or almost null and there was no significant difference
between CE group and non-CE group. (TIF 88 kb)
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